Casdin Capital, LLC Sarepta Therapeutics, Inc. Transaction History

Casdin Capital, LLC

$1.29 Billion
Q3 2024

A detailed history of Casdin Capital, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 1,073,500 shares of SRPT stock, worth $127 Million. This represents 10.42% of its overall portfolio holdings.

Number of Shares

1,073,500

Previous 1,073,500 -0.0%

Holding current value

$127 Million

Previous $170 Million 20.95%

% of portfolio

10.42%

Previous 14.63%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $509,985 - $737,325	4,500 Added 0.42%	1,073,500 $170 Million
Q1 2024 May 15, 2024	BUY	$93.7 - $141.53 $5.86 Million - $8.85 Million	62,500 Added 6.21%	1,069,000 $138 Million
Q4 2023 Feb 14, 2024	SELL	$67.31 - $124.76 $257,797 - $477,830	-3,830 Reduced 0.38%	1,006,500 $97.1 Million
Q3 2023 Nov 14, 2023	SELL	$102.5 - $123.59 $478,675 - $577,165	-4,670 Reduced 0.46%	1,010,330 $122 Million
Q2 2023 Aug 14, 2023	SELL	$106.4 - $157.19 $15.4 Million - $22.8 Million	-145,000 Reduced 12.5%	1,015,000 $116 Million
Q1 2023 May 15, 2023	SELL	$117.53 - $155.99 $18.2 Million - $24.2 Million	-155,000 Reduced 11.79%	1,160,000 $160 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $9.08 Million - $11.9 Million	90,000 Added 7.35%	1,315,000 $170 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $43.5 Million - $68.6 Million	575,000 Added 88.46%	1,225,000 $135 Million
Q2 2022 Aug 15, 2022	SELL	$62.69 - $88.44 $9.4 Million - $13.3 Million	-150,000 Reduced 18.75%	650,000 $48.7 Million
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $34.7 Million - $49.7 Million	-550,000 Reduced 40.74%	800,000 $62.5 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $19.3 Million - $24.9 Million	250,000 Added 22.73%	1,350,000 $122 Million
Q3 2021 Nov 15, 2021	BUY	$65.97 - $92.48 $14.2 Million - $19.9 Million	215,000 Added 24.29%	1,100,000 $102 Million
Q2 2021 Aug 16, 2021	BUY	$69.38 - $86.75 $23.2 Million - $29.1 Million	335,000 Added 60.91%	885,000 $68.8 Million
Q1 2021 May 17, 2021	BUY	$72.25 - $168.95 $1.45 Million - $3.38 Million	20,000 Added 3.77%	550,000 $41 Million
Q2 2020 Aug 14, 2020	SELL	$93.0 - $171.7 $13 Million - $24 Million	-140,000 Reduced 20.9%	530,000 $85 Million
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $16.1 Million - $28.5 Million	-210,000 Reduced 23.86%	670,000 $86.5 Million
Q3 2019 Nov 12, 2019	BUY	$72.81 - $156.91 $39.7 Million - $85.5 Million	545,000 Added 162.69%	880,000 $66.3 Billion
Q2 2019 Aug 13, 2019	BUY	$112.21 - $151.95 $3.37 Million - $4.56 Million	30,000 Added 9.84%	335,000 $0
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $16.5 Million - $23.5 Million	155,000 Added 103.33%	305,000 $36.4 Million
Q4 2018 Feb 13, 2019	BUY	$97.32 - $148.76 $10.7 Million - $16.4 Million	110,000 Added 275.0%	150,000 $16.4 Million
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $4.61 Million - $6.46 Million	40,000 New	40,000 $6.46 Million

Others Institutions Holding SRPT

# of Institutions

528

Shares Held

83.9M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.3B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Casdin Capital, LLC with notifications on news.

Account

Casdin Capital, LLC Sarepta Therapeutics, Inc. Transaction History